Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.

Scientists have unveiled a new fabrication technique for the ultra-clean manufacturing of 2D heterostructures—materials just ...

The development of self-driving cars faces significant liability and regulatory challenges, unlike the unfulfilled promise of flying cars. Nvidia's Xinzhou Wu detailed the evolution of autonomous EVs, ...